|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | GIP receptor antagonism reverses obesity,insulin resistance,and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet显示文摘 | McClean PL Irwin N Cassidy RS | | 0，，： | 1 |
| 2 | A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1AE9 mouse model of Alzheimer's disease 显示文摘 | Parthsarathy V McClean PL H~lscher C | 2013 | PLoS One2013，8，54： | 1 |
| 3 | The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease显示文摘 | McClean PL Parthsarathy V Faivre E | | 0，，17： | 1 |
| 4 | The diabetes drugliraglutide prevents degenerative processes in a mouse model ofAlzheimer's disease显示文摘 | McClean PL Parthsarathy V Faivre E | 2011 | The Journal of Neuroscience: the official journalof the Society for Neuroscience2011，31，17： | 1 |
| 5 | Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease显示文摘 | McClean PL Gault VA Harriott P | 2010 | Eur J Pharmacol2010，630，13： | 1 |
| 6 | Liraglutide can reverse memory impair- ment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer' s disease 显示文摘 | McClean PL Holseher C | 2014 | Neuropharmacology2014，76，： | 1 |
| 7 | The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer' s disease 显示文摘 | Mcclean PL Parthsarathy V Faivre E | 2011 | J Neurosci2011，31，17： | 1 |
| 8 | Liraglutide can reverse memory impair- ment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer' s disease 显示文摘 | Mcclean PL H61scher C | 2014 | Neuropharmacology2014，76，： | 1 |
| 9 | Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PSI mice, a model of Alzheimer's disease显示文摘 | McClean PL H61scher C | 2014 | Neuropharrnacology2014，76，： | 1 |
| 10 | Glucagon- likepeptide-1 analogues enhance synaptic plasticity in the brain:a link between diabetes and Alzheimer's disease显示文摘 | McClean PL Gault VA Harriott P | 2010 | Eur JPharmacol2010，630，13： | 1 |
| 11 | GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturba- nces induced in mice by prolonged consumption of high-fat diet显示文摘 | Mcclean PL Irwin N Cassidy RS | 2007 | Am J Physiol Endocfinol Metab2007，293，6： | 1 |
| 12 | Beneficial effects of sub-chronic activation of glucagon-like peptide-1(GLP-1)receptors on deteriorationof glucose homeostasis and insulin secretion in aging mice显示文摘 | Irwin N McClean PL Harriott P | 2007 | Exp Gerontol2007，42，4： | 1 |
| 13 | The diabetes drag liraglutide prevents degenerative processes in a mouse model of Mzheimer' s disease显示文摘 | McClean PL Parthsarathy V Faivre E | 2011 | J Neurosci2011，31，17： | 1 |
| 14 | The diabe- tes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease 显示文摘 | McClean PL Parthsarathy V Faivre E | 2011 | J Neurosci2011，31，： | 1 |
| 15 | The diabetes drug liraglu- tide prevents degenerative processes in a mouse model of alzheimer's disease显示文摘 | McClean PL Parthsarathy V Faivre E | 2011 | J Neurosei2011，31，17： | 1 |
| 16 | Active immunisation against gastric inhibitory polypeptide (GIP)improves blood glucose control in an animal model of obesity-diabetes显示文摘 | Irwin N McClean PL Patterson S | 2009 | Siol Chem2009，390，1： | 1 |
| 17 | The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease显示文摘 | McClean PL Parthsarathy V Faivre E | 2011 | J Neurosci2011，31，： | 1 |
| 18 | GIP receptor antagonism reverses obesity,insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet 显示文摘 | McClean PL Irwin N Cassidy RS | 2007 | Am J Physiol Endocrinol Metab2007，293，6： | 1 |
| 19 | Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high - fat and cafeteria diets 显示文摘 | Gault VA McClean PL Cassidy RS | 2007 | Diabetologia2007，50，8： | 1 |
| 20 | Early administration of the glucose - dependent insulinotropic polypeptide receptor antagonist (Pro3) GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice 显示文摘 | Irwin N McClean PL O'Harte FP | 2007 | Diabetologia2007，50，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员